Upstream processes

The core of the cell therapy upstream process is fermentation and preparation, whose core equipment directly determines downstream efficiency and product quality.Adopting an upstream‑downstream integrated strategy, Diwoxin has developed a high‑end intelligent platform that connects core fermentation equipment with downstream systems to maximize performance and drive the industrialization and standardization of upstream processes.

Synthetic biology-fermentation integration accelerates, driving biomanufacturing. Divoxin offers a reference; applications expand to mRNA vaccines.Challenges: traditional fermentation lags strains; data underutilized; strain construction ignores growth environments.Bridging gaps, collaboration and big data/AI integration are key for biomanufacturing industrialization.

This article explores the core of biopharmaceutical upstream processing: cell culture. It systematically describes mammalian cell culture modes (batch, fed-batch, perfusion), details the seed expansion strategy from cell banks to production bioreactors, and highlights how PAT and QbD frameworks enable lean control over cell growth and protein expression. It provides a comprehensive technical perspective on modern cell culture process development and execution.

This article focuses on the two pillars of upstream bioprocessing: culture media and bioreactors. It analyzes the logic of chemically defined media development and component optimization while comparing bioreactor types (stirred-tank vs. single-use) regarding design, operation, and scale-up. By explaining how these systems maintain the optimal environment for cell growth, it reveals the path to achieving robustness and economic efficiency in upstream processes.

This paper reviews cutting-edge trends and strategies in upstream bioprocessing. It discusses the shift from batch to continuous manufacturing, and how AI, machine learning and automation drive process intelligence. It also addresses new demands from cell and gene therapies and the outlook for green biomanufacturing, outlining the upcoming paradigm shift in upstream bioprocessing.